FEB 14, 2019 10:30 AM PST

Integrating In Vitro Microtissues and In Vivo endpoints in Drug Discovery & Development

C.E. Credits: RACE
Speaker
  • Associate Director of Mechanistic and Investigative Toxicology, Takeda Pharmaceuticals
    Biography
      Matt Wagoner leads the Global Investigatory Toxicology network for Takeda Pharmaceuticals, where their team applys microphysiological systems (MPS) as predictive and mechanistic toxicology tools in support of discovery-phase projects. Before Takeda, Matt led the mRNA safety strategy for AstraZeneca Pharmaceuticals, and worked to develop and deploy MPS tools in support of projects. Matt has his PhD in Molecular and Cellular Pharmacology from the University of Wisconsin-Madison and bachelors in biochemistry from the University of Illinois Urbana Champaign.

    Abstract

    This presentation will discuss and review the promise and potential of 3D Microtissues, and the challenges of using these Microtissues as Hazard ID tools. Lastly, we will discuss the potential application of Neural Microtissues in drug discovery screening. 

    Learning Objectives: 

    1. Understanding the strengths and limitations of in vitro and in vivo assays for hazard identification and risk assessment.  
    2. Examining how 3D Microtissues can improve hazard identification in drug discovery, and de-risking during drug development.  


    Show Resources
    You May Also Like
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    NOV 10, 2020 7:00 AM PST
    C.E. CREDITS
    NOV 10, 2020 7:00 AM PST
    DATE: November 10, 2020 TIME: 7:00am PDT, 10:00am EDT Automation can provide tremendous benefits such as increased pipetting precision and accuracy, productivity, and throughput. Numerous wo...
    OCT 22, 2020 8:00 AM PDT
    C.E. CREDITS
    OCT 22, 2020 8:00 AM PDT
    Abstract: Detection and/or amplification of target DNA sequences by polymerase chain reaction (PCR) is a prevalent method in molecular biology. PCR has a broad range of applications, includi...
    FEB 14, 2019 10:30 AM PST

    Integrating In Vitro Microtissues and In Vivo endpoints in Drug Discovery & Development

    C.E. Credits: RACE

    Specialty

    Animal Research

    Animal Models

    Life Science

    Research

    Animal Sciences

    Veterinary Sciences

    Animals

    Cancer Research

    Cancer

    Cell Biology

    Immunology

    Cell

    Molecular Biology

    Cell Culture

    Animal Behavior

    Geography

    Europe89%

    North America4%

    Asia3%

    Registration Source

    Website Visitors100%

    Job Title

    Student18%

    Post Doc15%

    Research Scientist14%

    Medical Laboratory Technician14%

    Scientist14%

    Educator/Faculty8%

    Medical Doctor/Specialist7%

    Facility/Department Manager3%

    Executive2%

    Lab Management2%

    Biologist1%

    Clinical Laboratory Scientist1%

    Organization

    Academic Institution54%

    Hospital16%

    Research Institute14%

    Pharmaceutical Company6%

    Industrial Company2%

    Life Science Company1%

    Medical Center1%

    Biotech Company1%

    Manufacturer & Biotech/pharma1%

    Government/public1%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more